Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer - Investigation of risk facter for colon cancer
Phase 2
Recruiting
- Conditions
- Colon cancer
- Registration Number
- JPRN-UMIN000003252
- Lead Sponsor
- Yamaguchi University Department of Srgery and Clinical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1) Contraindications of using UFT, LV, TS-1 2) active double cancer except ca. in situ 3) Severe postoperative complication 4) Serious coexisting illness a)uncontrolled diabetes mellitus b)uncontrolled hypertension c)history of myocardial infarction, unstable angina within 6 months prior to the registration severe d)liver cirrhosis e)pulmonary dysfunction 5) pregnant or nursing patient or with intent to bear baby 6) mental disorder or psychiatric symptom 7) HIV infection 8) Disqualified by attending doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse free survival
- Secondary Outcome Measures
Name Time Method Overall survival,Compliance, Relation of risk facter, Measurement of anticancer drug-sensitive facter